 |
市場調查報告書
商品編碼
2075343
犬類關節炎市場：依產品類型、最終用戶、治療方法和地區分類Canine Arthritis Market, By Product Type, By End User, By Treatment Type, By Geography |
||||||
價格
簡介目錄
2026年犬類關節炎市場規模估計為16億美元，預計2033年將達到28.5億美元。預計從2026年到2033年，該市場將以10.3%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 16億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 10.30% | 2033年市場規模預測： | 28.5億美元 |
全球犬類關節炎市場涵蓋非類固醇消炎劑(NSAIDs)、營養補充劑、退化性關節炎藥物 (DMOADs) 及類似產品。這些產品在獸醫診所、寵物店、網路藥局及其他通路銷售，並被各類終端用戶廣泛採用。隨著各機構日益重視產品性能、效率和成本效益，這些領域的市場需求持續穩定成長。
市場動態：
來自主要終端用戶產業的需求不斷成長、對更高效率和可靠性的需求以及持續的產品創新，預計將是推動全球犬類關節炎市場成長的主要因素。獸醫診所和寵物商店的廣泛應用也進一步增強了這種成長勢頭。
例如，市場新進業者正在實施專為獸醫醫院應用場景設計的先進解決方案。此外，預計在預測期內，持續的技術進步和策略投資將為市場新進入者創造新的成長機會。
本研究的主要特點：
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據公司概況、產品系列、主要亮點、財務表現和策略等參數，對全球犬類關節炎市場的主要參與者進行了分析。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份《全球犬類關節炎市場》報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以利用各種用於分析全球犬類關節炎市場的策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場概覽
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 影響分析
- 近期產品發布
- 流行病學
- 併購和合作
- 監管趨勢
- 主要進展
- PEST分析
- 夥伴關係方案
- 品牌和定價分析
- 銷售代理情況
- 波特的分析
- 技術進步
- 主要進展
- 市場趨勢
- 前景
- 按銷售收入排名的主要公司
第4章：犬類關節炎市場：依產品類型分類，2026-2033年
- 非類固醇消炎劑（NSAIDs）
- 營養保健品
- 骨關節炎的疾病修飾劑（DMOADs）
- 生物製劑
- 其他
第5章：犬類關節炎市場：依最終用戶分類，2026-2033年
- 動物診所
- 寵物專賣店
- 網路藥房
- 動物醫院
- 其他
第6章：犬類關節炎市場：依治療類型分類，2026-2033年
- 藥物治療
- 物理治療
- 手術介入
- 生活方式管理
- 其他
第7章：犬類關節炎市場：依地區分類，2026-2033年
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 比荷盧經濟聯盟
- 丹麥
- 挪威
- 瑞典
- 其他歐洲國家
- 亞太地區
- 中國
- 台灣
- 印度
- 日本
- 印尼
- 馬來西亞
- 菲律賓
- 新加坡
- 澳洲
- 韓國
- 其他亞太國家
- 中東和非洲
- 巴林
- 科威特
- 阿曼
- 卡達
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 北非
- 中非
- 其他中東國家
第1章 競爭情勢
- Zoetis Inc.
- Elanco Animal Health
- Merck Animal Health
- Dechra Pharmaceuticals PLC
- Vetoquinol SA
- Bayer AG
- Boehringer Ingelheim
- IDEXX Laboratories
- Heska Corporation
- Virbac Group
- Ceva Sante Animale
- Norbrook Laboratories
第2章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI2433
Canine Arthritis Market is estimated to be valued at USD 1.60 billion in 2026 and is expected to reach USD 2.85 billion by 2033, growing at a compound annual growth rate (CAGR) of 10.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1.60 billion |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.30% | 2033 Value Projection: | USD 2.85 billion |
The global canine arthritis market includes offerings that span Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Nutraceuticals, and Disease-Modifying Osteoarthritis Drugs (DMOADs), and similar product type categories. These are applied across Veterinary Clinics, Pet Specialty Stores, and Online Pharmacies and adopted by diverse end users. As organizations increasingly prioritize performance, efficiency, and cost-effectiveness, adoption across these segments continues to grow steadily.
Market Dynamics:
Increasing demand from major end-use sectors, the need for improved efficiency and reliability, and ongoing product innovation are major factors expected to drive growth of the global canine arthritis market. Broader adoption across Veterinary Clinics, and Pet Specialty Stores is reinforcing this momentum.
For instance, market players are introducing advanced solutions designed for Veterinary Clinics use cases. Moreover, continued technological advancement and strategic investment are expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global canine arthritis market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Merck Animal Health, Dechra Pharmaceuticals PLC, Vetoquinol SA, Bayer AG, Boehringer Ingelheim, IDEXX Laboratories, Heska Corporation, Virbac Group, Ceva Sant Animale, and Norbrook Laboratories, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global canine arthritis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global canine arthritis market.
Detailed Segmentation:
- Global Canine Arthritis Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Nutraceuticals
- Disease-Modifying Osteoarthritis Drugs (DMOADs)
- Biologics
- Others
- Global Canine Arthritis Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Veterinary Clinics
- Pet Specialty Stores
- Online Pharmacies
- Animal Hospitals
- Others
- Global Canine Arthritis Market, By Treatment Type (Revenue, USD Bn, 2021 - 2033)
- Pharmacological Treatment
- Physical Therapy
- Surgical Intervention
- Lifestyle Management
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Zoetis Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Elanco Animal Health
- Merck Animal Health
- Dechra Pharmaceuticals PLC
- Vetoquinol SA
- Bayer AG
- Boehringer Ingelheim
- IDEXX Laboratories
- Heska Corporation
- Virbac Group
- Ceva Sant Animale
- Norbrook Laboratories
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Treatment Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective
- Top Market Players by Revenue
4. Canine Arthritis Market By Product Type, 2026-2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Disease-Modifying Osteoarthritis Drugs (DMOADs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
5. Canine Arthritis Market By End User, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Pet Specialty Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Animal Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
6. Canine Arthritis Market By Treatment Type, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Pharmacological Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Physical Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Surgical Intervention
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Lifestyle Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (US$ Billion)
7. Canine Arthritis Market By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, en2026-2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Benelux
- Denmark
- Norway
- Sweden
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- Taiwan
- India
- Japan
- Indonesia
- Malaysia
- Philippines
- Singapore
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- UAE
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East
1. Competitive Landscape
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dechra Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vetoquinol SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bayer AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IDEXX Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Heska Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Virbac Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Norbrook Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
2. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
維生素D咀嚼片市場：全球市場預測，2026-2032年犬類關節炎市場：2026-2032年全球市場預測（依治療方法、藥物類別、給藥途徑、最終用戶和分銷管道分類）犬用咀嚼片市場：依給藥頻率、分銷形式、動物年齡層、成分類型、包裝規格、價格範圍、重量分類、口味、產品類型、最終用戶、分銷管道分類－全球預測，2026-2032年
犬類關節炎治療市場機會、成長要素、產業趨勢分析及2026年至2035年預測拉米夫定咀嚼片市場按包裝類型、年齡層、劑量強度、口味、治療適應症、分銷管道和最終用戶分類，全球預測，2026-2032年
犬類關節炎治療市場規模、佔有率和成長分析（按關節炎類型、給藥途徑、治療方法、最終用戶、分銷管道和地區分類）—產業預測（2026-2033 年）